Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection of Patients for Maintenance Therapy
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (4) , 540-545
- https://doi.org/10.1097/jto.0b013e3181d3504d
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Maintenance therapy in nonsmall‐cell lung cancerCancer, 2009
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyThe Lancet, 2009
- Duration of Chemotherapy for Metastatic Non–Small-Cell Lung Cancer: More May Be Better After AllJournal of Clinical Oncology, 2009
- Re-Evaluating Duration of Therapy in Advanced Non–Small-Cell Lung Cancer: Is It Really Duration or Is It More About Timing and Exposure?Journal of Clinical Oncology, 2009
- The role of maintenance chemotherapy in advanced nonsmall cell lung cancerCurrent Opinion in Oncology, 2009
- Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or ObservationJournal of Clinical Oncology, 2003
- Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering ResultsJournal of Clinical Oncology, 2001